203 related articles for article (PubMed ID: 16707852)
1. Expression of myoferlin in skeletal muscles of patients with dysferlinopathy.
Inoue M; Wakayama Y; Kojima H; Shibuya S; Jimi T; Oniki H; Nishino I; Nonaka I
Tohoku J Exp Med; 2006 Jun; 209(2):109-16. PubMed ID: 16707852
[TBL] [Abstract][Full Text] [Related]
2. Myoferlin, a candidate gene and potential modifier of muscular dystrophy.
Davis DB; Delmonte AJ; Ly CT; McNally EM
Hum Mol Genet; 2000 Jan; 9(2):217-26. PubMed ID: 10607832
[TBL] [Abstract][Full Text] [Related]
3. Tetraspanin CD82 Associates with Trafficking Vesicle in Muscle Cells and Binds to Dysferlin and Myoferlin.
Fontelonga T; Hall AJ; Brown JL; Jung YL; Alexander MS; Dominov JA; Mouly V; Vieira N; Zatz M; Vainzof M; Gussoni E
Adv Biol (Weinh); 2023 Dec; 7(12):e2300157. PubMed ID: 37434585
[TBL] [Abstract][Full Text] [Related]
4. [Dysferlin expression in limb-girdle muscular dystrophy and Miyoshi myopathy: analysis of 45 cases].
Ren SC; Yan CZ; Li MX; Liu SP; Wu JL; Zhao YY; Li W; Li DN
Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(21):1486-90. PubMed ID: 17785089
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemistry of sarcolemmal membrane-associated proteins in formalin-fixed and paraffin-embedded skeletal muscle tissue: a promising tool for the diagnostic evaluation of common muscular dystrophies.
Suriyonplengsaeng C; Dejthevaporn C; Khongkhatithum C; Sanpapant S; Tubthong N; Pinpradap K; Srinark N; Waisayarat J
Diagn Pathol; 2017 Feb; 12(1):19. PubMed ID: 28219397
[TBL] [Abstract][Full Text] [Related]
6. Lack of correlation between outcomes of membrane repair assay and correction of dystrophic changes in experimental therapeutic strategy in dysferlinopathy.
Lostal W; Bartoli M; Roudaut C; Bourg N; Krahn M; Pryadkina M; Borel P; Suel L; Roche JA; Stockholm D; Bloch RJ; Levy N; Bashir R; Richard I
PLoS One; 2012; 7(5):e38036. PubMed ID: 22666441
[TBL] [Abstract][Full Text] [Related]
7. Protein and gene analyses of dysferlinopathy in a large group of Japanese muscular dystrophy patients.
Tagawa K; Ogawa M; Kawabe K; Yamanaka G; Matsumura T; Goto K; Nonaka I; Nishino I; Hayashi YK
J Neurol Sci; 2003 Jul; 211(1-2):23-8. PubMed ID: 12767493
[TBL] [Abstract][Full Text] [Related]
8. Dysferlin protein analysis in limb-girdle muscular dystrophies.
Vainzof M; Anderson LV; McNally EM; Davis DB; Faulkner G; Valle G; Moreira ES; Pavanello RC; Passos-Bueno MR; Zatz M
J Mol Neurosci; 2001 Aug; 17(1):71-80. PubMed ID: 11665864
[TBL] [Abstract][Full Text] [Related]
9. Dysferlin and myoferlin regulate transverse tubule formation and glycerol sensitivity.
Demonbreun AR; Rossi AE; Alvarez MG; Swanson KE; Deveaux HK; Earley JU; Hadhazy M; Vohra R; Walter GA; Pytel P; McNally EM
Am J Pathol; 2014 Jan; 184(1):248-59. PubMed ID: 24177035
[TBL] [Abstract][Full Text] [Related]
10. Dysferlin is a surface membrane-associated protein that is absent in Miyoshi myopathy.
Matsuda C; Aoki M; Hayashi YK; Ho MF; Arahata K; Brown RH
Neurology; 1999 Sep; 53(5):1119-22. PubMed ID: 10496277
[TBL] [Abstract][Full Text] [Related]
11. Loss of dysferlin or myoferlin results in differential defects in excitation-contraction coupling in mouse skeletal muscle.
Barefield DY; Sell JJ; Tahtah I; Kearns SD; McNally EM; Demonbreun AR
Sci Rep; 2021 Aug; 11(1):15865. PubMed ID: 34354129
[TBL] [Abstract][Full Text] [Related]
12. The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle.
Matsuda C; Hayashi YK; Ogawa M; Aoki M; Murayama K; Nishino I; Nonaka I; Arahata K; Brown RH
Hum Mol Genet; 2001 Aug; 10(17):1761-6. PubMed ID: 11532985
[TBL] [Abstract][Full Text] [Related]
13. Disruption of muscle membrane and phenotype divergence in two novel mouse models of dysferlin deficiency.
Ho M; Post CM; Donahue LR; Lidov HG; Bronson RT; Goolsby H; Watkins SC; Cox GA; Brown RH
Hum Mol Genet; 2004 Sep; 13(18):1999-2010. PubMed ID: 15254015
[TBL] [Abstract][Full Text] [Related]
14. Intracellular accumulation and reduced sarcolemmal expression of dysferlin in limb--girdle muscular dystrophies.
Piccolo F; Moore SA; Ford GC; Campbell KP
Ann Neurol; 2000 Dec; 48(6):902-12. PubMed ID: 11117547
[TBL] [Abstract][Full Text] [Related]
15. Dysferlin mediates membrane tubulation and links T-tubule biogenesis to muscular dystrophy.
Hofhuis J; Bersch K; Büssenschütt R; Drzymalski M; Liebetanz D; Nikolaev VO; Wagner S; Maier LS; Gärtner J; Klinge L; Thoms S
J Cell Sci; 2017 Mar; 130(5):841-852. PubMed ID: 28104817
[TBL] [Abstract][Full Text] [Related]
16. Dysferlin and the plasma membrane repair in muscular dystrophy.
Bansal D; Campbell KP
Trends Cell Biol; 2004 Apr; 14(4):206-13. PubMed ID: 15066638
[TBL] [Abstract][Full Text] [Related]
17. Calpain-3 and dysferlin protein screening in patients with limb-girdle dystrophy and myopathy.
Fanin M; Pegoraro E; Matsuda-Asada C; Brown RH; Angelini C
Neurology; 2001 Mar; 56(5):660-5. PubMed ID: 11245721
[TBL] [Abstract][Full Text] [Related]
18. Defective membrane repair in dysferlin-deficient muscular dystrophy.
Bansal D; Miyake K; Vogel SS; Groh S; Chen CC; Williamson R; McNeil PL; Campbell KP
Nature; 2003 May; 423(6936):168-72. PubMed ID: 12736685
[TBL] [Abstract][Full Text] [Related]
19. Dysferlin interacts with calsequestrin-1, myomesin-2 and dynein in human skeletal muscle.
Flix B; de la Torre C; Castillo J; Casal C; Illa I; Gallardo E
Int J Biochem Cell Biol; 2013 Aug; 45(8):1927-38. PubMed ID: 23792176
[TBL] [Abstract][Full Text] [Related]
20. Sarcolemmal proteins and the spectrum of limb-girdle muscular dystrophies.
Bönnemann CG; Finkel RS
Semin Pediatr Neurol; 2002 Jun; 9(2):81-99. PubMed ID: 12139001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
